Fibrotic Strictures and Anti-TNF-α Therapy in Crohn’s Disease

By  

Digestion, Vol. 75, Iss. 1, 2007-04 ,pp. : 22-24

Karger

Access to resources Recommend Favorite

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

Anti-TNF-α therapy in membranous glomerulonephritis

By Santoro Domenico   Postorino Adele   Costantino Giuseppe   Savica Vincenzo   Bellinghieri Guido  

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 487-488

Oxford University Press

Access to resources Recommend Favorite

Psoriasis occurring during anti-TNF-α therapy: causal effect or unrelated?

By Stratigos Alexander J   Sfikakis Petros P  

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 281-284

Future Medicine

Access to resources Recommend Favorite

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

By Nakashima Yasuharu   Kondo Masakazu   Harada Hiroshi   Horiuchi Takahiko   Ishinishi Takashi   Jojima Hiroshi   Kuroda Koji   Miyahara Hisaaki   Nagamine Ryuji   Nakashima Hitoshi   Otsuka Takeshi   Saikawa Isao   Shono Eisuke   Suematsu Eiichi   Tsuru Tomomi   Wada Ken   Iwamoto Yukihide  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 343-352

Springer Publishing Company

Access to resources Recommend Favorite